Head-to-head · Cost-Efficiency Index
Invyncible vs TeleCareSpot
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Invyncible
Cost-first shoppers who want compounded GLP-1 combo programs (with B12/glycine) alongside brand Wegovy/Zepbound on one platform.
Visit InvyncibleTeleCareSpot
Shoppers comparing headline monthly rates who are willing to call/email for the real dose-tier breakdown.
Visit TeleCareSpotThe verdict
Invyncible and TeleCareSpot tie on the Cost-Efficiency Index at 59/100, so neither wins outright on the numbers. For most shoppers we'd start with Invyncible (ranked #272, a hair above #277) — Cost-first shoppers who want compounded GLP-1 combo programs (with B12/glycine) alongside brand Wegovy/Zepbound on one platform. But TeleCareSpot is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Invyncible.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Invyncible | TeleCareSpot |
|---|---|---|
| Cost-Efficiency Index | 59/100 | 59/100 |
| Semaglutide / mo | $149/mo (0.45 mg dose, compounded with glycine + B12) | $299/mo (compounded) |
| Tirzepatide / mo | $180/mo (2.5 mg weekly, 4-week program, compounded) | $399/mo (compounded oral) |
| Semaglutide / yr (modeled) | $1,788 | $3,588 |
| Tirzepatide / yr (modeled) | $2,160 | $4,788 |
| Coverage | 46 states plus DC | 48 states |
| Oral / sublingual | Yes | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #272 | #277 |
Invyncible
59/100Where the value is
- Publishes real itemized dollar prices for eight separate combo programs plus two brand options directly on the site, no signup required, with the mg vial size named in every dose option
- Sells FDA-approved brand Wegovy ($1,750/mo) and Zepbound ($1,540/mo) alongside compounded options
- Names all six compounding pharmacies with street addresses and phone numbers and lets the patient choose which one fills the prescription
The tradeoffs
- Every listed price is shown as a discount off a much higher struck-through 'list' price, and the page invites further negotiation — reads as permanent anchor pricing
- The entry figure is the smallest vial: plain compounded semaglutide runs $192.50, $262.50 and $350 across its three vial sizes, and the FAQ confirms cost rises with dose
TeleCareSpot
59/100Where the value is
- LegitScript verification badge displayed on-site
- Offers both injectable and oral tirzepatide options
- Serves nearly all US states (only AK, MS, NJ excluded)
The tradeoffs
- 'From' pricing with no dose-tier breakdown -- real cost at your prescribed dose is unclear upfront
- No medical director named anywhere on the site
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.